Global Hepatitis C Virus (HCV) Antiviral Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

世界の抗C型肝炎ウイルス市場

◆タイトル:Global Hepatitis C Virus (HCV) Antiviral Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
◆商品コード:QYR8D04727
◆調査・発行会社:QYResearch
◆発行日:2018年12月
◆ページ数:111
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国
◆産業分野:材料・化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,600 ⇒換算¥604,800見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD11,200 ⇒換算¥1,209,600見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは、世界の抗C型肝炎ウイルス市場について調査・分析し、種類別には、C型肝炎ウイルス抗体、C 型肝炎ウイルス、C 型肝炎ウイルス遺伝子型に、用途別には、診断センター 、病院、家庭用に区分してまとめました。以下の目次構成(日本語)は参考用です。

・レポートの概要
・グローバル成長トレンド
・抗C型肝炎ウイルスの世界市場規模
・抗C型肝炎ウイルスの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別抗C型肝炎ウイルスの価格動向
・抗C型肝炎ウイルスの種類別市場規模(C型肝炎ウイルス抗体、C 型肝炎ウイルス、C 型肝炎ウイルス遺伝子型)
・抗C型肝炎ウイルスの用途別市場規模(診断センター 、病院、家庭用)
・抗C型肝炎ウイルスの北米市場(アメリカ、カナダ、メキシコ)
・抗C型肝炎ウイルスのヨーロッパ市場(ドイツ、フランス、イギリス、イタリア、ロシア)
・抗C型肝炎ウイルスのアジア市場(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・抗C型肝炎ウイルスの中南米市場(ブラジル等)
・抗C型肝炎ウイルスの中東・アフリカ市場(GCC、エジプト、南アフリカ)
・主要企業情報
 -企業概要、事業概要、販売・売上・市場シェア、製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・抗C型肝炎ウイルスの市場規模予測
・抗C型肝炎ウイルスの種類別市場予測2018-2025(C型肝炎ウイルス抗体、C 型肝炎ウイルス、C 型肝炎ウイルス遺伝子型)
・抗C型肝炎ウイルスの用途別市場予測2018-2025(診断センター 、病院、家庭用)
・抗C型肝炎ウイルスの北米市場予測2018-2025(アメリカ、カナダ、メキシコ)
・抗C型肝炎ウイルスのヨーロッパ市場予測2018-2025(ドイツ、フランス、イギリス、イタリア、ロシア)
・抗C型肝炎ウイルスのアジア市場予測2018-2025(日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム)
・抗C型肝炎ウイルスの中南米市場予測2018-2025(ブラジル等)
・抗C型肝炎ウイルスの中東・アフリカ市場予測2018-2025(GCC、エジプト、南アフリカ)
・調査結果及び結論

Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.The Hepatitis C Virus (HCV) Antiviral market was valued at xx Million US$ in 2017 and is projected to reach xx Million US$ by 2025, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Hepatitis C Virus (HCV) Antiviral.

This study focuses on the production side and consumption side of Hepatitis C Virus (HCV) Antiviral, presents the global Hepatitis C Virus (HCV) Antiviral market size by manufacturers, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
In terms of production side, this report researches the Hepatitis C Virus (HCV) Antiviral capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and product type.
In terms of consumption side, this report focuses on the consumption of Hepatitis C Virus (HCV) Antiviral by regions and application. The key regions like North America, Europe, Asia-Pacific, Central & South America, Middle East and Africa etc.

This report includes the following manufacturers; we can also add the other companies as you want.
Roche Diagnostics
Abbott
Siemens
Qiagen
bioMérieux
Bio-Rad Laboratories
Meridian Bioscience
Vista Diagnostics
Biogate Laboratories
J.Mitra & Co. Ltd
Siemens Medical
General Biologicals

Market Segment by Product Type
HCV Antibody
HCV Viral Load
HCV Genotyping

Market Segment by Application
Diagnostic Centers
Hospitals
Home Use

Key Regions split in this report:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa

The study objectives are:
To analyze and research the global Hepatitis C Virus (HCV) Antiviral status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Hepatitis C Virus (HCV) Antiviral manufacturers, capacity, production, revenue, market share, and recent development.
To split the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Hepatitis C Virus (HCV) Antiviral are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type
1.3.2 HCV Antibody
1.3.3 HCV Viral Load
1.3.4 HCV Genotyping
1.4 Market Segment by Application
1.4.1 Global Hepatitis C Virus (HCV) Antiviral Market Share by Application (2018-2025)
1.4.2 Diagnostic Centers
1.4.3 Hospitals
1.4.4 Home Use
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Hepatitis C Virus (HCV) Antiviral Production Value 2013-2025
2.1.2 Global Hepatitis C Virus (HCV) Antiviral Production 2013-2025
2.1.3 Global Hepatitis C Virus (HCV) Antiviral Capacity 2013-2025
2.1.4 Global Hepatitis C Virus (HCV) Antiviral Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2018-2025
2.2.1 Global Hepatitis C Virus (HCV) Antiviral Market Size CAGR of Key Regions
2.2.2 Global Hepatitis C Virus (HCV) Antiviral Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Hepatitis C Virus (HCV) Antiviral Capacity by Manufacturers
3.1.2 Global Hepatitis C Virus (HCV) Antiviral Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Hepatitis C Virus (HCV) Antiviral Revenue by Manufacturers (2013-2018)
3.2.2 Hepatitis C Virus (HCV) Antiviral Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Hepatitis C Virus (HCV) Antiviral Market Concentration Ratio (CR5 and HHI)
3.3 Hepatitis C Virus (HCV) Antiviral Price by Manufacturers
3.4 Key Manufacturers Hepatitis C Virus (HCV) Antiviral Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hepatitis C Virus (HCV) Antiviral Market
3.6 Key Manufacturers Hepatitis C Virus (HCV) Antiviral Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 HCV Antibody Production and Production Value (2013-2018)
4.1.2 HCV Viral Load Production and Production Value (2013-2018)
4.1.3 HCV Genotyping Production and Production Value (2013-2018)
4.2 Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Type
4.3 Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share by Type
4.4 Hepatitis C Virus (HCV) Antiviral Ex-factory Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Hepatitis C Virus (HCV) Antiviral Consumption by Application

6 Production by Regions
6.1 Global Hepatitis C Virus (HCV) Antiviral Production (History Data) by Regions 2013-2018
6.2 Global Hepatitis C Virus (HCV) Antiviral Production Value (History Data) by Regions
6.3 United States
6.3.1 United States Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2013-2018
6.3.2 United States Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018
6.3.3 Key Players in United States
6.3.4 United States Hepatitis C Virus (HCV) Antiviral Import & Export
6.4 Europe
6.4.1 Europe Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2013-2018
6.4.2 Europe Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018
6.4.3 Key Players in Europe
6.4.4 Europe Hepatitis C Virus (HCV) Antiviral Import & Export
6.5 China
6.5.3 Key Players in China
6.5.2 China Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018
6.5.3 Key Players in China
6.5.4 China Hepatitis C Virus (HCV) Antiviral Import & Export
6.6 Japan
6.6.1 Japan Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2013-2018
6.6.2 Japan Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018
6.6.3 Key Players in Japan
6.6.4 Japan Hepatitis C Virus (HCV) Antiviral Import & Export
6.7 Other Regions
6.7.1 South Korea
6.7.2 India
6.7.3 Southeast Asia

7 Hepatitis C Virus (HCV) Antiviral Consumption by Regions
7.1 Global Hepatitis C Virus (HCV) Antiviral Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Hepatitis C Virus (HCV) Antiviral Consumption by Type
7.2.2 North America Hepatitis C Virus (HCV) Antiviral Consumption by Application
7.2.3 North America Hepatitis C Virus (HCV) Antiviral Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Hepatitis C Virus (HCV) Antiviral Consumption by Type
7.3.2 Europe Hepatitis C Virus (HCV) Antiviral Consumption by Application
7.3.3 Europe Hepatitis C Virus (HCV) Antiviral Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption by Type
7.4.2 Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption by Application
7.4.3 Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption by Countries
7.4.4 China
7.4.5 Japan
7.4.6 Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Hepatitis C Virus (HCV) Antiviral Consumption by Type
7.5.2 Central & South America Hepatitis C Virus (HCV) Antiviral Consumption by Application
7.5.3 Central & South America Hepatitis C Virus (HCV) Antiviral Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption by Type
7.6.2 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption by Application

8 Company Profiles
8.1 Roche Diagnostics
8.1.1 Roche Diagnostics Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.1.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.1.5 Roche Diagnostics Recent Development
8.2 Abbott
8.2.1 Abbott Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.2.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.2.5 Abbott Recent Development
8.3 Siemens
8.3.1 Siemens Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.3.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.3.5 Siemens Recent Development
8.4 Qiagen
8.4.1 Qiagen Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.4.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.4.5 Qiagen Recent Development
8.5 bioMérieux
8.5.1 bioMérieux Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.5.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.5.5 bioMérieux Recent Development
8.6 Bio-Rad Laboratories
8.6.1 Bio-Rad Laboratories Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.6.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.6.5 Bio-Rad Laboratories Recent Development
8.7 Meridian Bioscience
8.7.1 Meridian Bioscience Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.7.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.7.5 Meridian Bioscience Recent Development
8.8 Vista Diagnostics
8.8.1 Vista Diagnostics Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.8.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.8.5 Vista Diagnostics Recent Development
8.9 Biogate Laboratories
8.9.1 Biogate Laboratories Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.9.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.9.5 Biogate Laboratories Recent Development
8.10 J.Mitra & Co. Ltd
8.10.1 J.Mitra & Co. Ltd Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Hepatitis C Virus (HCV) Antiviral
8.10.4 Hepatitis C Virus (HCV) Antiviral Product Introduction
8.10.5 J.Mitra & Co. Ltd Recent Development
8.11 Siemens Medical
8.12 General Biologicals

9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Hepatitis C Virus (HCV) Antiviral Capacity, Production Forecast 2018-2025
9.1.2 Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast 2018-2025
9.2 Hepatitis C Virus (HCV) Antiviral Production and Production Value Forecast by Regions
9.2.1 Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast by Regions
9.2.2 Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Regions
9.3 Hepatitis C Virus (HCV) Antiviral Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.3.5 Other Regions
9.4 Forecast by Type
9.4.1 Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Type
9.4.2 Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast by Type

10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Countries 2018-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Countries 2018-2025
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Countries 2018-2025
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Country 2018-2025
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Countries 2018-2025
10.7.2 Middle East and Africa
10.7.3 GCC Countries
10.7.4 Egypt
10.7.5 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hepatitis C Virus (HCV) Antiviral Sales Channels
11.2.2 Hepatitis C Virus (HCV) Antiviral Distributors
11.3 Hepatitis C Virus (HCV) Antiviral Customers

12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis

13 Key Findings

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

List of Tables and Figures

Figure Hepatitis C Virus (HCV) Antiviral Product Picture
Table Hepatitis C Virus (HCV) Antiviral Key Market Segments
Table Major Manufacturers Hepatitis C Virus (HCV) Antiviral Covered in This Report
Table Global Hepatitis C Virus (HCV) Antiviral Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Hepatitis C Virus (HCV) Antiviral Sales Market Shar by Type 2013-2025
Figure HCV Antibody Figures
Table Major Manufacturers of HCV Antibody
Figure HCV Viral Load Figures
Table Major Manufacturers of HCV Viral Load
Figure HCV Genotyping Figures
Table Major Manufacturers of HCV Genotyping
Table Global Hepatitis C Virus (HCV) Antiviral Market Share by Application 2018-2025 (K Units)
Figure Diagnostic Centers Use Case
Figure Hospitals Use Case
Figure Home Use Use Case
Figure Hepatitis C Virus (HCV) Antiviral Report Years Considered
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2025 (Million US$)
Figure Global Hepatitis C Virus (HCV) Antiviral Production 2013-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Capacity 2013-2025 (K Units)
Table Key Manufacturers Hepatitis C Virus (HCV) Antiviral Capacity (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Price 2013-2025 (USD/Unit)
Table Global Hepatitis C Virus (HCV) Antiviral Market Size of Key Regions (Million USD) & (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Growth Rate of Key Regions 2018-2025 (Million USD)
Table Global Hepatitis C Virus (HCV) Antiviral Market Share for of Regions 2018-2025 (K Units)
Table Market Top Trends
Table Global Hepatitis C Virus (HCV) Antiviral Capacity by Manufacturers (2013-2018) (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Capacity Market Share by Manufacturers (2013-2018)
Table Global Hepatitis C Virus (HCV) Antiviral Production by Manufacturers (2013-2018) (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Production Share by Manufacturers (2013-2018)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Share by Manufacturers in 2017
Table Hepatitis C Virus (HCV) Antiviral Revenue by Manufacturers (2013-2018) (Million USD)
Table Hepatitis C Virus (HCV) Antiviral Revenue Share by Manufacturers (2013-2018)
Figure Hepatitis C Virus (HCV) Antiviral Value Share by Manufacturers in 2017
Table Global Hepatitis C Virus (HCV) Antiviral Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Hepatitis C Virus (HCV) Antiviral Price by Manufacturers 2013-2018 (USD/Unit)
Table Key Manufacturers Hepatitis C Virus (HCV) Antiviral Plants/Factories Distribution
Table Key Manufacturers Hepatitis C Virus (HCV) Antiviral Area Served
Table Date of Key Manufacturers Enter into Hepatitis C Virus (HCV) Antiviral Market
Table Key Manufacturers Hepatitis C Virus (HCV) Antiviral Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global HCV Antibody Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global HCV Viral Load Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global HCV Genotyping Production and Production Value (2013-2018) (K Units) & (Million US$)
Table Global Hepatitis C Virus (HCV) Antiviral Production by Type (2013-2018) (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Production Share by Type (2013-2018)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Type (2013-2018)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Type in 2017
Table Global Hepatitis C Virus (HCV) Antiviral Production Value by Type (2013-2018) (Million US$)
Table Global Hepatitis C Virus (HCV) Antiviral Production Value Share by Type (2013-2018)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share by Type (2013-2018)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share by Type in 2017
Table Hepatitis C Virus (HCV) Antiviral Ex-factory Price by Type 2013-2018 (USD/Unit)
Table Global Hepatitis C Virus (HCV) Antiviral Consumption by Application (2013-2018) (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Consumption Share by Application (2013-2018)
Figure Global Consumption Hepatitis C Virus (HCV) Antiviral Market Share by Application (2013-2018)
Table Global Hepatitis C Virus (HCV) Antiviral Production by Regions 2013-2018 (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Regions 2013-2018
Figure Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Regions 2013-2018
Figure Global Hepatitis C Virus (HCV) Antiviral Production Market Share by Regions in 2017
Table Global Hepatitis C Virus (HCV) Antiviral Production Value by Regions 2013-2018 (Million USD)
Table Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share by Regions 2013-2018
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share by Regions 2013-2018
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share by Regions in 2017
Table United States Hepatitis C Virus (HCV) Antiviral Production and Value 2013-2018 (K Units) & (Million USD)
Figure United States Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2013-2018 (K Units)
Figure United States Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018 (Million USD)
Table United States Hepatitis C Virus (HCV) Antiviral Import & Export (K Units)
Table Europe Hepatitis C Virus (HCV) Antiviral Production and Value 2013-2018 (K Units) & (Million USD)
Figure Europe Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2013-2018 (K Units)
Figure Europe Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018 (Million USD)
Table Europe Hepatitis C Virus (HCV) Antiviral Import & Export (K Units)
Table China Hepatitis C Virus (HCV) Antiviral Production and Value 2013-2018 (K Units) & (Million USD)
Figure China Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2013-2018 (K Units)
Figure China Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018 (Million USD)
Table China Hepatitis C Virus (HCV) Antiviral Import & Export (K Units)
Table Japan Hepatitis C Virus (HCV) Antiviral Production and Value 2013-2018 (K Units) & (Million USD)
Figure Japan Hepatitis C Virus (HCV) Antiviral Production Growth Rate 2013-2018 (K Units)
Figure Japan Hepatitis C Virus (HCV) Antiviral Production Value Growth Rate 2013-2018 (Million USD)
Table Japan Hepatitis C Virus (HCV) Antiviral Import & Export (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Consumption by Regions 2013-2018 (K Units)
Table Global Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Regions 2013-2018
Figure Global Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Regions 2013-2018
Figure Global Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Regions in 2017
Figure North America Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Table North America Hepatitis C Virus (HCV) Antiviral Consumption by Type (2013-2018) (K Units)
Figure North America Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Type in 2018
Table North America Hepatitis C Virus (HCV) Antiviral Consumption by Application (2013-2018) (K Units)
Figure North America Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Application in 2018
Table North America Hepatitis C Virus (HCV) Antiviral Consumption by Countries (2013-2018) (K Units)
Figure North America Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Countries in 2018
Figure United States Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Canada Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Mexico Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Europe Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Table Europe Hepatitis C Virus (HCV) Antiviral Consumption by Type (2013-2018) (K Units)
Figure Europe Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Type in 2018
Table Europe Hepatitis C Virus (HCV) Antiviral Consumption by Application (2013-2018) (K Units)
Figure Europe Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Application in 2018
Table Europe Hepatitis C Virus (HCV) Antiviral Consumption by Countries (2013-2018) (K Units)
Figure Europe Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Countries in 2018
Figure Germany Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure France Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure UK Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Italy Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Russia Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Table Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption by Type (2013-2018) (K Units)
Figure Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Type in 2018
Table Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption by Application (2013-2018) (K Units)
Figure Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Application in 2018
Table Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption by Countries (2013-2018) (K Units)
Table Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Countries (2013-2018)
Figure China Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Japan Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Korea Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure India Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Australia Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Indonesia Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Thailand Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Malaysia Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Philippines Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Vietnam Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Central & South America Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Table Central & South America Hepatitis C Virus (HCV) Antiviral Consumption by Type (2013-2018) (K Units)
Figure Central & South America Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Type in 2018
Table Central & South America Hepatitis C Virus (HCV) Antiviral Consumption by Application (2013-2018) (K Units)
Figure Central & South America Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Application in 2018
Table Central & South America Hepatitis C Virus (HCV) Antiviral Consumption by Countries (2013-2018) (K Units)
Figure Central & South America Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Countries
Figure Brazil Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption Growth Rate (2013-2018) (K Units)
Table Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption by Type (2013-2018) (K Units)
Figure 2017 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Type
Table Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption by Application (2013-2018) (K Units)
Figure 2017 Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption Market Share by Application
Table Roche Diagnostics Company Details
Table Roche Diagnostics Description and Business Overview
Table Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Roche Diagnostics Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Roche Diagnostics Recent Development
Table Abbott Company Details
Table Abbott Description and Business Overview
Table Abbott Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Abbott Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Abbott Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Abbott Recent Development
Table Siemens Company Details
Table Siemens Description and Business Overview
Table Siemens Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Siemens Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Siemens Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Siemens Recent Development
Table Qiagen Company Details
Table Qiagen Description and Business Overview
Table Qiagen Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Qiagen Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Qiagen Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Qiagen Recent Development
Table bioMérieux Company Details
Table bioMérieux Description and Business Overview
Table bioMérieux Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table bioMérieux Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table bioMérieux Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table bioMérieux Recent Development
Table Bio-Rad Laboratories Company Details
Table Bio-Rad Laboratories Description and Business Overview
Table Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Bio-Rad Laboratories Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Bio-Rad Laboratories Recent Development
Table Meridian Bioscience Company Details
Table Meridian Bioscience Description and Business Overview
Table Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Meridian Bioscience Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Meridian Bioscience Recent Development
Table Vista Diagnostics Company Details
Table Vista Diagnostics Description and Business Overview
Table Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Vista Diagnostics Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Vista Diagnostics Recent Development
Table Biogate Laboratories Company Details
Table Biogate Laboratories Description and Business Overview
Table Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table Biogate Laboratories Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table Biogate Laboratories Recent Development
Table J.Mitra & Co. Ltd Company Details
Table J.Mitra & Co. Ltd Description and Business Overview
Table J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Production (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Production Growth Rate (2013-2018)
Table J.Mitra & Co. Ltd Hepatitis C Virus (HCV) Antiviral Production Market Share in Global Market
Table J.Mitra & Co. Ltd Recent Development
Table Siemens Medical Company Details
Table General Biologicals Company Details
Table Global Hepatitis C Virus (HCV) Antiviral Capacity, Production Forecast 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Capacity Forecast 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Forecast 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast 2018-2025 (Million US$)
Table Global Hepatitis C Virus (HCV) Antiviral Revenue Forecast 2018-2025 (Million US$)
Table Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast by Regions 2018-2025 (Million US$)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast by Regions 2018-2025 (Million US$)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share Forecast by Regions 2018-2025
Table Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Regions 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Regions 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Market Share Forecast by Regions 2018-2025
Table United States Hepatitis C Virus (HCV) Antiviral Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure United States Hepatitis C Virus (HCV) Antiviral Production Forecast 2018-2025 (K Units)
Figure United States Hepatitis C Virus (HCV) Antiviral Revenue Forecast 2018-2025 (Million US$)
Table Europe Hepatitis C Virus (HCV) Antiviral Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure Europe Hepatitis C Virus (HCV) Antiviral Production Forecast 2018-2025 (K Units)
Figure Europe Hepatitis C Virus (HCV) Antiviral Revenue Forecast 2018-2025 (Million US$)
Table China Hepatitis C Virus (HCV) Antiviral Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure China Hepatitis C Virus (HCV) Antiviral Production Forecast 2018-2025 (K Units)
Figure China Hepatitis C Virus (HCV) Antiviral Revenue Forecast 2018-2025 (Million US$)
Table Japan Hepatitis C Virus (HCV) Antiviral Production and Value Forecast 2018-2025 (K Units) & (Million US$)
Figure Japan Hepatitis C Virus (HCV) Antiviral Production Forecast 2018-2025 (K Units)
Figure Japan Hepatitis C Virus (HCV) Antiviral Revenue Forecast 2018-2025 (Million US$)
Table Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Type 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Forecast by Type 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Market Share Forecast by Type 2018-2025
Table Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast by Type 2018-2025 (Million US$)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Forecast by Type 2018-2025 (Million US$)
Figure Global Hepatitis C Virus (HCV) Antiviral Production Value Market Share Forecast by Type 2018-2025
Table Global Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Application 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Application 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Consumption Market Share Forecast by Application 2018-2025
Table Global Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2018-2025 (K Units)
Figure Global Hepatitis C Virus (HCV) Antiviral Consumption Market Share Forecast by Regions 2018-2025
Table North America Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2018-2025 (K Units)
Figure United States Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Canada Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure MexicoHepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Table Europe Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2018-2025 (K Units)
Figure Germany Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure France Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure UK Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Italy Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Russia Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Table Asia Pacific Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2018-2025 (K Units)
Figure China Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Japan Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Korea Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure India Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Australia Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Indonesia Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Thailand Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Malaysia Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Philippines Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure Vietnam Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Table Central & South America Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2018-2025 (K Units)
Figure Brazil Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Table Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption Forecast by Regions 2018-2025 (K Units)
Figure Middle East and Africa Hepatitis C Virus (HCV) Antiviral Consumption Forecast 2018-2025 (K Units)
Figure GCC Countries Hepatitis C Virus (HCV) Antiviral Sales Growth Rate (2018-2025) (K Units)
Figure Egypt Hepatitis C Virus (HCV) Antiviral Sales Growth Rate (2018-2025) (K Units)
Figure South Africa Hepatitis C Virus (HCV) Antiviral Sales Growth Rate (2018-2025) (K Units)
Figure Hepatitis C Virus (HCV) Antiviral Value Chain
Table Hepatitis C Virus (HCV) Antiviral Distributors List
Table Hepatitis C Virus (HCV) Antiviral Customers List
Table Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の抗C型肝炎ウイルス市場] (Global Hepatitis C Virus (HCV) Antiviral Industry Research Report, Growth Trends and Competitive Analysis 2018-2025 / QYR8D04727)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆